C. Fisser (Regensburg, Germany), J. Winck (Vila Nova de Gaia, Portugal)
Serum markers of endothelial dysfunction and invasive mechanical ventilation in COVID-19
L. Cornejo-Cornejo (Mexico City, Mexico), A. Orea-Tejeda (Mexico City, Mexico), D. Gonzalez-Islas (Mexico City, Mexico), J. Marquez-Cordero (Mexico City, Mexico), A. Rios-Pereda (Mexico City, Mexico), J. Aguilar-Meza (Mexico City, Mexico), M. Salvatierra-Escobar (Mexico City, Mexico), I. Lopez-Vazquez (Mexico City, Mexico), C. Sanchez-Moreno (Mexico City, Mexico), L. Hernandez-Urquieta (Mexico City, Mexico), A. Loaeza-Roman (Mexico City, Mexico), J. Garcia-Hernandez (Mexico City, Mexico), Y. Debray-Garcia (Mexico City, Mexico), M. Sierra-Vargas (Mexico City, Mexico), G. Aztatzi-Aguilar (Mexico City, Mexico)
|   |
PSP kinetics in the prediction of VAP diagnosis
A. Ceccato (Barcelona, Spain), M. Camprubi (Barcelona, Spain), L. Bos (Amsterdam, Netherlands), P. Povoa (Lisbon, Portugal), I. Martin-Loeches (Dublin, Ireland), A. Areny (Barcelona, Spain), E. Campaña (Barcelona, Spain), L. Morales (Barcelona, Spain), P. Ramirez (Valencia, Spain), M. Esperatti (Mar del Plata, Argentina), A. Torres (Barcelona, Spain), A. Artigas (Barcelona, Spain)
| |
C3a and C5b-9 levels differentially predict COVID-19 severity and mortality.
M. Detsika (Athens, Greece), E. Diamanti (Athens, Greece), K. Ampelakiotou (Athens, Greece), E. Jahaj (Athens, Greece), S. Tsipilis (Athens, Greece), N. Athanasiou (Athens, Greece), A. Zacharis (Athens, Greece), I. Dimopoulou (Athens, Greece), S. Orfanos (Athens, Greece), A. Tsirogianni (Athens, Greece), A. Kotanidou (Athens, Greece)
| |
Calcium-sensing receptor signalling and neutrophil dysfunction: implications in critical illness
P. Yarova (Newcastle upon Tyne, United Kingdom), J. Scott (Newcastle upon Tyne, United Kingdom), V. Telezhkin (Newcastle upon Tyne, United Kingdom), E. Turnbull (Newcastle upon Tyne, United Kingdom), C. Merrill (Newcastle upon Tyne, United Kingdom), B. Patchett (Newcastle upon Tyne, United Kingdom), M. Ruchaud-Sparagano (Newcastle upon Tyne, United Kingdom), K. Musgrave (Newcastle upon Tyne, United Kingdom), D. Bulmer (Newcastle upon Tyne, United Kingdom), D. Riccardi (Cardiff, United Kingdom), A. Rostron (Newcastle upon Tyne, United Kingdom), T. Hellyer (Newcastle upon Tyne, United Kingdom), J. Simpson (Newcastle upon Tyne, United Kingdom)
| |
A pilot trial for ozanimod therapy in hospitalized COVID-19 patients
D. Marsolais (Quebec, Canada), N. Châteauvert (Quebec, Canada), P. Blais-Lecours (Quebec, Canada), P. Rola (Montreal, Canada), T. Nguyen (Laval, Canada), F. Lellouche (Quebec, Canada)
| |
Towards a better diagnostic and treatment of ventilator-associated respiratory infections.
A. PALOMEQUE FLORES (BARCELONA, Spain), R. López (BARCELONA, Spain), A. Soler (BARCELONA, Spain), L. Bueno (BARCELONA, Spain), N. Rovira (BARCELONA, Spain), E. Barbeta (BARCELONA, Spain), A. Motos (BARCELONA, Spain), M. Villanueva (BARCELONA, Spain), N. Vázques (BARCELONA, Spain), R. Cabrera (BARCELONA, Spain), A. Torres* (BARCELONA, Spain), L. Fernández-Barat* (BARCELONA, Spain)
| |
Importance of alveolo-arterial oxygen gradient in monitoring moderate/severe forms of COVID-19
C. Tusa (Cluj-Napoca, Romania), A. Prodisteanu (Cluj-Napoca, Romania), D. Moldovan (Cluj-Napoca, Romania), L. Cardos-Rosca (Cluj-Napoca, Romania)
| |
Outcome of patients admitted in Covid ICU during first wave and second wave in Mumbai Tertiary Hospital
R. BHINGARDEVE (MUMBAI, India), S. Mante (MUMBAI, India), N. Ajwani (MUMBAI, India), S. Thorve (MUMBAI, India), S. Waghmare (MUMBAI, India), J. Nair (MUMBAI, India)
| |
The Utility of Estimating the Shunt Fraction of Critical Patients with COVID-19 in determining the outcome of High Flow Nasal Cannula at Lung Center of the Philippines, a pilot study.
M. Gabitan (Quezon City, Philippines), S. Ganangan (Quezon City, Philippines)
| |
Clinical Profile and Outcomes of COVID19 confirmed cases with Acute Respiratory Distress Syndrome Undergoing Protocol directed assisted Prone Positioning at Lung Center of the Philippines (LCP) from May 1, 2020 to April 30, 2021
K. Acibal (Quezon City, Philippines), N. Gomez (Quezon City, Philippines), P. Tanyag (Quezon City, Philippines)
| |
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
C. Franceschini (Caba, Argentina), J. Rodriguez (Caba, Argentina), M. Wysocki (Caba, Argentina), M. Kleinert (Caba, Argentina), C. Cozzani (Caba, Argentina), M. Torres Boden (Caba, Argentina), J. Giorgini (Caba, Argentina), O. Saque (Caba, Argentina), A. Sanchez Andia (Caba, Argentina), A. Olmos (Caba, Argentina), M. Finadesio (Caba, Argentina), E. Santilli (Caba, Argentina), D. Nahmias (Caba, Argentina), B. Frias (Caba, Argentina), M. Olave (Caba, Argentina), L. Ciaponi (Caba, Argentina), M. Henriquez Salazar (Caba, Argentina)
| |
Ventilator associated pneumonia surveillance in critically ill patients with COVID-19 in a tertiary care hospital
D. Karadeniz Güven (Ankara, Turkey), G. Telli Dizman (Ankara, Turkey), G. Metan (Ankara, Turkey), G. Durhan (Ankara, Turkey), A. Topeli (Ankara, Turkey), A. Demir (Ankara, Turkey)
| |
Impact of combined non-invasive support strategies use during acute respiratory failure due to COVID-19.
J. Marin Corral (Barcelona, Spain), F. Parrilla (Barcelona, Spain), M. Restrepo (San Antonio, United States), S. Pascual-Guardia (Barcelona, Spain), A. Rodriguez (Tarragona, Spain), J. Ballesteros (Salamanca, Spain), S. Sancho (Valencia, Spain), L. Socias (Palma de Mallorca, Spain), E. Diaz (Sabadell, Spain), A. Albaya-Moreno (Guadalajara, Spain), J. Masclans (Barcelona, Spain)
| |
The successful use of Pezzer Catheter in Covid-19 patients
K. Athanassiadi (Athens, Greece), S. Mitrou (Athens, Greece), E. Ischaki (Athens, Greece), M. Kazantzi (Athens, Greece), I. Galanis (Athens, Greece), E. Liverakou (Athens, Greece), A. Sarri (Athens, Greece), S. Kokkoris (Athens, Greece), Z. Mastora (Athens, Greece)
| |
Delay of intensive care admission of severe COVID-19 patients : what impact on mortality ?
F. Essafi (Zaghouan, Tunisia), I. Talik (Zaghouan, Tunisia), K. Ben Ismail (Zaghouan, Tunisia), M. Kharrat (Zaghouan, Tunisia), N. Ben Slimene (Zaghouan, Tunisia), A. Bayoudh (Zaghouan, Tunisia), I. Fessi (Zaghouan, Tunisia), M. Kaddour (Zaghouan, Tunisia), T. Merhabene (Zaghouan, Tunisia)
| |
Relationship between blood gases and inflammatory markers with clinical outcomes in critically ill patients with COVID-19
N. Morais (Mossoró, Brazil), L. Candice Costa De Morais Leonez (Mossoró, Brazil), V. Duarte De Almeida (Mossoró, Brazil), M. Fernandes De Andrade (Mossoró, Brazil), E. Gurgel Cosme Do Nascimento (Mossoró, Brazil), J. Veríssimo Fernandes (Natal, Brazil), C. Medeiros Bezerra (Natal, Brazil), T. Allyrio Araújo De Medeiros Fernandes (Mossoró, Brazil)
| |
Utilization of corticosteroids among patients died with COVID 19: A single center experience from a resource poor setting
A. Rathnapala (Minuwangoda, Sri Lanka), . Imbulpitiya (Kandy, Sri Lanka), P. Attanayake (Kandy , Sri Lanka), P. Liyanage (Kandy , Sri Lanka), A. Siribaddna (Kandy , Sri Lanka)
| |
Clinical and laboratory characteristics of patients who succumbed to COVID-19: a single center experience from a resource poor setting
A. Rathnapala (Minuwangoda, Sri Lanka), B. Imbulpitiya (Kandy, Sri Lanka), P. Attanayake (Kandy, Sri Lanka), P. Liyanage (Kandy, Sri Lanka), A. Siribaddana (Kandy, Sri Lanka)
| |
Comparing the effect of strict versus routine awake prone positioning among patients hospitalized withCOVID-19
S. Ashraf (Peshawar, Pakistan), H. Asif (Peshawar, Pakistan), A. Ashraf (Peshawar, Pakistan)
| |
Clinical effects and mortality of farilty in geriatric COVID-19 patients
Z. SAHIN ERÖKSÜZ (Istanbul, Turkey), S. Olgun Yildizeli? (Istanbul, Turkey)
| |